The renewed malaria eradication efforts require an understanding of the seasonal patterns of frequency of polymorphic variants in order to focus limited funds productively. Although cross-sectional studies in holoendemic areas spanning a single year could be useful in describing parasite genotype status at a given point, such information is inadequate in describing temporal trends in genotype polymorphisms. For Plasmodium falciparum isolates from Kisumu District Hospital, Plasmodium falciparum chloroquine-resistance transporter gene (Pfcrt-K76T) and P. falciparum multidrug resistance gene 1 (PfMDR1-N86Y), were analyzed for polymorphisms and parasitemia changes in the 53 months from March 2008 to August 2012. Observations were compared with prevailing climatic factors, including humidity, rainfall, and temperature. Methods: Parasitemia (the percentage of infected red blood cells per total red blood cells) was established by microscopy for P. falciparum malaria-positive samples. P. falciparum DNA was extracted from whole blood using a Qiagen DNA Blood Mini Kit. Single nucleotide polymorphism identification at positions Pfcrt-K76T and PfMDR1-N86Y was performed using real-time polymerase chain reaction and/or sequencing. Data on climatic variables were obtained from http://www.tutiempo.net/en/. Results: A total of 895 field isolates from 2008 (n=169), 2009 (n=161), 2010 (n=216), 2011 (n=223), and 2012 (n=126) showed large variations in monthly frequency of PfMDR1-N86Y and Pfcrt-K76T as the mutant genotypes decreased from 68.4%±15% and 38.1%±13% to 29.8%±18% and 13.3%±9%, respectively. The mean percentage of parasitemia was 2.61%±1.01% (coefficient of variation 115.86%; n=895). There was no correlation between genotype or parasitemia and climatic factors. Conclusion: This study shows variability in the frequency of Pfcrt-K76T and PfMDR1-N86Y polymorphisms during the study period, bringing into focus the role of cross-sectional studies in describing temporal genotype trends. The lack of correlation between genotypes and climatic changes, especially precipitation, emphasizes the cost of investment in genotype change.
Introduction
There has been a steady increase in funding from the international community to tackle malaria in the last few years. 1, 2 This has led to a rapid scaling up of malaria control measures in many countries, especially Africa. 3, 4 This has supported the expansion of malaria control interventions, such as the procurement and distribution of artemisininbased combination therapy and other antimalarial drugs, insecticide-treated bed nets, and other mosquito vector control strategies. 5 Without a licensed vaccine, chemoprophylaxis and chemotherapy play a central role in combating malaria infections, 6 and will continue
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akala et al to do so for the foreseeable future. 7 Emergence of rapid drug resistance has proven challenging and tends to derail progress made towards malaria control, despite changes in policies that govern treatment of uncomplicated malaria. [8] [9] [10] Therapeutic efficacy studies are the gold standard for measuring antimalarial drug resistance and drug efficacy. However, the simplicity, robustness, and scalability of molecular resistance markers make them an attractive substitute for efficacy studies. Molecular markers have been used by policy makers as part of evidence in decision-making for malaria drug treatment policies [11] [12] [13] [14] [15] and to monitor changes in parasite drug susceptibility following implementation of new policies. 16 Mutations that confer resistance can lower the fitness of resistant parasites relative to sensitive ones when drug pressure declines, imposing a genetic "cost" of resistance to the mutant population. 17 Studies have demonstrated that a rapid shift in the genetic parasite populations does occur once the drug pressure is withdrawn. [17] [18] [19] This event is most likely to be explained by the fitness cost incurred as a result of drug resistance. The genetic changes that occur during the period when drug treatment policy for specific drug regimens is changed or implemented 20 define a critical role of drug pressure in evolutionary host-parasite adaptation. Another factor that might play a critical role in this evolutionary adaptation is the environment. In areas of seasonal malaria transmission, studies have shown seasonal fluctuation in the frequencies of drug-resistant alleles, which tend to be lower during the wet season when compared with the dry season. [21] [22] [23] [24] Understanding of persistence and fluctuation of drugresistant and drug-sensitive parasites during the dry season (especially in an almost therapy-free environment) in areas of seasonal transmission is of great importance and particularly relevant to the question of costs of drug resistance. 22, 23 This information is useful in establishing disease eradication interventions. However, similar data from holoendemic regions with year-round transmission that would be useful in accounting for other factors that influence drug resistance polymorphisms besides drug pressure are lacking.
Diversity of the Plasmodium falciparum population in the natural environment plays a critical role in facilitating immune escape and overcoming chemotherapeutic agents. [25] [26] [27] [28] [29] Parasite diversity is influenced by the transmission intensity and level of endemicity, 30, 31 and the inherent polymorph flexibility is mediated by rapid allele changes. 28 The parasite population structure in holoendemic areas shows multiplicity of infections owing to elevated host immunity and chemotherapeutic drug pressure. Theoretical studies describe the emergence of resistance in South East Asia as a product of low immunity selecting resistant strains. 32 These factors influence the parasite's attempt to establish a balance of fitness and virulence across seasons, 28, 33 implying a resource allocation dilemma 34 as exemplified by delayed clearance of drug-resistant genotypes during treatment follow-up. 35, 36 We have previously reported P. falciparum genotype prevalence as either cross-section or trends within stipulated periods of time. [37] [38] [39] [40] Data from these studies were reported as clusters of periods between 2 and 5 years. Similarly, studies generating data that form the basis of mathematical modeling are usually reported as intercepts within broad linear correlates, summarizing trends and depicting gradual changes in drug susceptibility or prevalence of single nucleotide polymorphisms (SNPs). [41] [42] [43] In most studies, temporal changes are depicted in clusters of periods, mostly 1 year or more. In addition, most of these data do not explicitly indicate the months of the year when the data were collected, so might not capture real-time transitions or dynamics of a parasite population throughout the year or over the cluster of a stipulated period. Such data just give an endpoint result, fail to capture real-time transitions or the dynamics of a parasite population, and might not depict accurate genetic events taking place. Such data also underestimate the role of natural environmental conditions (which fluctuate even in holoendemic areas) in outlining parasite-host interaction despite innovation of accurate disease prediction. 33, 44 In the current study, we monitored the persistence and/or fluctuation of drug-resistant and drug-sensitive parasite polymorphisms in a holoendemic region of Western Kenya from 2008 to 2012 on a monthly basis. Mutation analysis was done for P. falciparum multidrug resistance gene 1 (PfMDR1-N86Y) and chloroquine resistance transporter gene (Pfcrt-K76T) in samples collected from subjects presenting with noncomplicated malaria at Kisumu District Hospital. Polymorphisms in these positions have been shown to influence treatment outcomes. 16 Environmental factors, including humidity, rainfall, and mean daily temperature, were also considered in the analysis. Previously, we reported dramatic changes in PfMDR1-N86Y and Pfcrt-K76T polymorphisms, 38 but the role of weather and parasitemia was not addressed. 
Materials and methods
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P. falciparum allele frequencies in a holoendemic area WRAIR 1384). The study site was the Kisumu District Hospital located in a lowland area holoendemic for malaria. 45 Other site characteristics, subject enrollment, sample collection, and subject follow-ups have been published elsewhere. 37 
Data collection
Upon reaching the malaria drug resistance laboratory, P. falciparum DNA was extracted from whole blood using a Qiagen DNA Blood Mini Kit (Qiagen Inc., Alameda, CA, USA), according to the manufacturer's instructions. SNP identification at positions K76T of the Pfcrt gene and N86Y, W184F, S1034C, and N1042D of the PfMDR1 gene were performed as previously described. 37 Diagnosis of malaria and quantification of parasitemia was performed as described earlier in literature. 46 Data on climatic variables were obtained from Tutiempo, 47 as measurements of mean daily temperature, percentage humidity, and precipitation.
Data analysis
Prism version 4.0 software for Windows (Graphpad Software, San Diego, CA, USA) and Sigma Plot 12 (Systat Software Inc., Chicago, IL, USA) were used to perform the data analysis, including descriptive and correlation statistics. Descriptive statistics were used to describe changes in climatic variables and genotype prevalence. For correlation, logistic regression was performed between each climatic variable versus parasite genotype or parasitemia using Stata version 12 software (Stata Corporation, College Station, TX, USA). The univariate and multivariate models were run with the 76 mutant (M) and 86 M set as reference.
Results
longitudinal monthly distribution of parasite drug resistance polymorphism
Eight hundred and ninety-five field isolates from Kisumu District Hospital were analyzed for polymorphism at codon Table 1 . There was a dramatic increase in the 76 W allele and a decrease in the 76 M allele from 2008 to 2012, as shown by the strong negative relationship coefficient of correlation (-0.7920). However, the monthly distribution of the polymorphism for parasite drug resistance varied from month to month (Figure 1 ). For example, the frequency of the 76 W allele was 48% in June 2010 but dropped to 8% in August, and to 0% in the following 2 months. This was followed by an increase to 100% in November of the same year 
changes in climatic conditions
The climatic conditions for Kisumu during the study period are summarized in Table 2 correlation between parasitemia and climatic factors Tables 3-5 show the linear regression performed using the Spearman rank correlation to test for a correlation between initial parasitemia and climatic conditions, including the precipitation, temperature, and humidity prevailing at the time of sample collection. These factors influence disease transmission, and were investigated alongside parasitemia at the onset of clinical symptoms of the disease. Parasitemia and humidity profiles for the period are summarized in Figure 2 . In a univariate model, initial parasitemia correlated significantly with humidity (Spearman rank coefficient -0.022, P=0.047). Linear regression was performed to test for an independent association between parasitemia and codon 86 and 76 polymorphisms. There was no correlation between parasitemia and polymorphism at codon 86. Similar trends were observed with codon 76 M and 76 WM. However, codon 76 W showed elevated mean parasitemia compared with 76 M and 76 WM (3.006%±3.219%; Table 5 ). This observation shows that no specific allele was associated with elevated parasitemia.
Precipitation and snP prevalence
Discussion
P. falciparum polymorphisms
P. falciparum infections exhibit genetic diversity that is an aggregate of ecological factors and host-parasite interactions. 28, 30, 48 Although a common origin has been proposed for P. falciparum, [49] [50] [51] parasite traits are in a state of continual change, unique to disease habitat. 18, 22, 28, 52 Understanding trends in genotype frequency is useful in disease management. 20, 51 Our data on the real-time dynamics of the PfMDR1 gene codon 86 and Pfcrt gene codon 76 allele frequencies in a natural environment reveals dramatic fluctuations across time in the course of their decline or ascension.
PfMDR1-86 and Pfcrt-76 polymorphisms
Longitudinal monitoring of codon 76 and 86 alleles across 53 months showed high fluctuation, indicative of immense P. falciparum genotype variability (coefficient of variation 36-106, Table 1 and Figure 1 ). The net change in allele frequency, described as the difference between the frequency at the beginning and end of the study, was five-fold and two-fold for 76 W and 86 W, with an inverse two-fold reduction for 76 M and 86 M, respectively. PfMDR1 codons 184, 1034 showed similar trends (data not shown). Concurrently, 76 WM had a two-fold increase in frequency while 86 WM decreased two-fold. The gross effect of these changes indicated a transition towards wild-type for both alleles. However, it is noteworthy that there were months with a more than 50-fold fluctuation in frequency for both alleles. This observation is somewhat interesting in the view of the perception that genotype frequency changes during a drug policy period are the product of drug pressure, 16, 51, 53 precipitating a perception of a somewhat linear trend.
During the 53 months, the codon 76 W allele was lost for 14 months, 76 WM for 4 months, 86 M for 4 months, and 86 WM for 9 months, while 76 M and 86 W were stable at variable frequencies (Figure 1 ). Most conspicuous was K76, which was lost in October 2009 and reappeared in March 2010, gradually rising to 100% in the subsequent 6 months. The 6-month period of increasing 76 W caused changes in allele frequencies. Similar tendencies were observed for codon 86 in December 2010 to March 2011, separated with the fact that this genotype passed difference in the wild-type genotype to mixed infection rather that the mutant genotype. The scale of changes and the rate at which they occurred in this study area are somewhat dramatic (Figures 1 and 2 , Table 1 ), bringing into focus the validity of findings from cross-sectional studies in high transmission that span across few months.
climatic factors and malaria
The Lake Victoria basin of Kenya is classified as a holoendemic malaria zone with an asymptomatic malaria rate of 50%. 54 The high mean parasitemia of 2.6% indicates high immunity. Interestingly, parasitemia remained stable during the study period, despite increased access to Coartem ® (an artemether/lumefantrine combination) during this period. 55, 56 Parasitemia has been shown to be protective and to prevent development of clinical malaria, 57, 58 confirmed by development of symptoms upon emergence of new strains. 59, 60 For the results of the current study, we suggest that humidity could be a confounder in the development of clinical malaria or treatment-seeking habits in Kisumu due to the significant negative correlation (P=0.047).
Rainfall and temperature showed no correlation with parasitemia. Shanks et al reported that, although temperature is useful in vector longevity, parasite development in vector and transmission to humans; it does not correlate with parasitemia or clinical symptoms of malaria. 61 It has also been established that although precipitation modulates 
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P. falciparum allele frequencies in a holoendemic area humidity and temperature that are key in transmission, it does not affect the parasite directly. 62 The lack of change across rainy seasons suggests genotype stability. Although environmental factors have been associated with changes in P. falciparum genotype in areas with distinct seasons, it is apparent that holoendemic areas need other factors to warrant genotype change.
Genetic changes that occur during the policy period of specific drug regimens and are lost upon withdrawal 18, 20 have defined the central role of drug pressure in host-parasite evolutionary adaptation. The role of environmental factors in shaping parasite genetics has been described by studies in regions with distinct transmission seasons. 52, 63 This study bridges the gap by providing real-time information on gene dynamics in a holoendemic, high transmission area with short erratic dry spells. Interestingly, it shows that there is no association between precipitation and PfMDR1-86 or Pfcrt-76 polymorphisms.
Conclusion
Fluctuation in SNPs occurred in Kenya during the study period, although there was only one policy that recommended medication as the principal source of drug pressure. This fluctuation suggests that there could be other factors besides drug pressure driving changes in PfMDR1-86 and Pfcrt-76 polymorphisms. Due to high variability, apparent from the monthly changes in frequencies, it is imperative that data originating from cross-sectional studies spanning across a limited number of months in a year be reported as a specific period status, and not intercepts of a predictable trend.
This study was based in a hospital outpatient department, and recruited individuals seeking treatment for symptomatic malaria. The mean parasitemia of 2.6% was rather high, and did not decrease across the study period despite increased access to Coartem during this time. This confirms that the rate of asymptomatic malaria is rather high, adding to empirical evidence suggesting that the malaria parasite has evolved alongside humanity in the region for centuries. In holoendemic areas, it has been shown that the parasite is capable of remaining in the blood system without causing symptoms of disease, subject to changes in factors influencing the host-parasite ecosystem equilibrium interface. 58 This is underscored by the fact that parasitemia remained high during the study period, despite increased penetration of Coartem treatment.
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